DataExa is a comprehensive artificial intelligence empowerment platform focused on delivering tailored AI solutions across multiple industries. The company has developed a range of products, including its flagship DataExa-Sati Cognitive Intelligence Platform, which leverages general knowledge graph technology. Other notable offerings include the DataExa-Maya intelligent question-answering platform, the DataExa-Kamala natural language processing platform, and the DataExa-Rama search platform. These tools have been successfully implemented in sectors such as defense, banking, securities, public security, civil aviation, and healthcare. By emphasizing value discovery, utilization, and innovation, DataExa creates self-learning industry knowledge maps that enhance big data solutions, enabling organizations to effectively incorporate data and knowledge mapping into their operations.
GRIT Biotechnology
Series B in 2023
GRIT Biotechnology, established in 2019 and based in Shanghai, China, specializes in the research and development of Tumor Infiltration Lymphocytes (TIL) immunotherapy for treating solid tumors. The company aims to enhance cancer therapies by focusing on this innovative approach.
ICE Bioscience
Series B in 2023
ICE Bioscience Inc. is a contract research organization based in Beijing, China, specializing in preclinical research solutions for electrophysiology and drug discovery. Founded in 2010, the company focuses on the development of ion channel-related drugs, particularly targeting the nervous and cardiovascular systems. ICE Bioscience offers a range of services, including ion channel screening, cardiac safety panels, and molecular biology, utilizing proprietary cell lines for voltage-gated and ligand-gated ion channels. The company is also dedicated to expanding its capabilities in immunology, oncology, and other areas, providing comprehensive support for target validation and preclinical candidate identification. Through its advanced screening platforms and flexible collaboration models, ICE Bioscience aims to enhance the efficiency of the drug discovery process for various clinical needs.
Astronergy
Series C in 2023
Astronergy is a manufacturing firm that specializes in the research, development, and production of solar modules to generate clean energy. Established in 2006, it is recognized as the first large-scale producer of high-efficiency thin film photovoltaic (PV) modules in mainland China. The company is a trusted provider of both monocrystalline and polycrystalline PV modules and focuses on creating high-efficiency crystalline silicon solar cells and modules. These products are designed for various applications, including utility-scale power stations, commercial and industrial PV systems, and residential PV systems. Astronergy aims to deliver high-quality and high-performance photovoltaic solutions to support the global transition to renewable energy.
DataExa is a comprehensive artificial intelligence empowerment platform focused on delivering tailored AI solutions across multiple industries. The company has developed a range of products, including its flagship DataExa-Sati Cognitive Intelligence Platform, which leverages general knowledge graph technology. Other notable offerings include the DataExa-Maya intelligent question-answering platform, the DataExa-Kamala natural language processing platform, and the DataExa-Rama search platform. These tools have been successfully implemented in sectors such as defense, banking, securities, public security, civil aviation, and healthcare. By emphasizing value discovery, utilization, and innovation, DataExa creates self-learning industry knowledge maps that enhance big data solutions, enabling organizations to effectively incorporate data and knowledge mapping into their operations.
Global Technology
Series C in 2023
Global Technology is a prominent supplier of automotive intelligent driving systems, headquartered in Shanghai, China. The company focuses on the development and integration of advanced automotive technologies, offering a range of products including electronic parking brakes (EPB), pneumatic and hydraulic anti-lock braking systems (ABS), electronic stability programs (ESP), and advanced driver-assistance systems (ADAS). As a high-tech enterprise, Global Technology excels in research and development, alongside a comprehensive capability in vehicle system matching. The firm is supported by a team of senior technical experts specializing in automotive pneumatics, hydraulic braking, and electronic control, enabling it to perform OEM market model matching analysis and advance automotive technology development.
Hydrogen Technology
Venture Round in 2023
Hydrogen Technology focuses on the research and development and industrialization of fuel cell engines. Its main business includes the production and sales of fuel cell engine products and the provision of integrated engineering services for fuel cell vehicles.
The company was founded in 2016 and is headquartered in Hangzhou, China.
Vapo Health
Venture Round in 2023
Vapo Health is a medical device company based in Kunshan City, China, focused on developing, manufacturing, and distributing products for respiratory system health. Established in 2015, the company employs advanced nano-scale atomized micro-hole technology to enhance drug delivery and particle efficiency in its offerings. Its product range includes nebulizers, spacers, thermometers, intelligent breathing trainers, and aerosol devices, as well as OEM and ODM services. Vapo Health aims to provide innovative and effective solutions to support respiratory health recovery and improve patient outcomes.
Astronergy
Series B in 2023
Astronergy is a manufacturing firm that specializes in the research, development, and production of solar modules to generate clean energy. Established in 2006, it is recognized as the first large-scale producer of high-efficiency thin film photovoltaic (PV) modules in mainland China. The company is a trusted provider of both monocrystalline and polycrystalline PV modules and focuses on creating high-efficiency crystalline silicon solar cells and modules. These products are designed for various applications, including utility-scale power stations, commercial and industrial PV systems, and residential PV systems. Astronergy aims to deliver high-quality and high-performance photovoltaic solutions to support the global transition to renewable energy.
Beijing Consen Automation
Venture Round in 2022
Beijing Consen Automation Control specializes in the development and provision of automation control systems for the petrochemical industry and railway signal control systems. The company offers a range of comprehensive solutions focused on safety and emergency control, including safety operation management systems and safety instrumented systems. By delivering these advanced control systems and control valves, Beijing Consen Automation aims to enhance production safety for its industry clients.
AIForceTech
Series A in 2022
AIForceTech is a Beijing-based company founded in 2019 that focuses on agricultural robotics and smart machinery. It specializes in the research, development, and manufacturing of robotic products designed to enhance efficiency in the agriculture sector. The company is advancing the deployment of unmanned pure electric tractors and a range of electric-powered agricultural robots. These innovative solutions leverage artificial intelligence and autonomous driving technology, allowing tractors to operate without human intervention both day and night. AIForceTech's products are actively utilized in real-world agricultural scenarios, providing the company with valuable practical insights and experience in the field.
Safe Medical Evaluation
Series D in 2022
SAFE Pharmaceutical, officially known as Beijing Saifu Medical Research Institute Co., Ltd., operates as a Contract Research Organization (CRO) specializing in pharmaceutical research and development services. The company collaborates with esteemed institutions such as the Shanghai Institute of Materia Medica and the National Drug Safety Evaluation and Research Center, leveraging their expertise to enhance its operational capabilities. With a core team comprised of experienced researchers from prestigious scientific organizations, SAFE Pharmaceutical offers comprehensive services that include R&D consulting, toxicology evaluations, and clinical trial design. This integrated approach allows pharmaceutical developers to efficiently advance their product research and development initiatives, supported by strong technical expertise and management experience in drug development and GLP compliance.
ZSHK Laboratories
Series B in 2022
ZSHK Lab is a company located in Wan Chai, Hong Kong Island, Hong Kong.
NewBanker
Series C in 2022
NewBanker, formally known as Beijing Niubitou Science and Technology Consulting, specializes in providing comprehensive support services for the wealth management industry in China. The company is founded by experienced managers from prominent wealth management firms and focuses on delivering information, research, technology, capital, and resources to wealth management companies and financial advisors. NewBanker develops customer relationship management software tailored for the wealth management sector, offering a SaaS/PaaS business support system that includes various services such as strategic research, industry information, investor education, and high-end training. Additionally, the firm provides a site acquisition system and technical support, ensuring its clients have access to essential tools and insights necessary for effective customer acquisition and industry promotion.
Hefei Sineva Intelligent Machine Co., Ltd., established in 2013 and located in Hefei, China, specializes in the research, development, manufacturing, and sales of transfer, test, and service robots. The company operates under the umbrella of Zhejiang Qianjiang Biochemical Co., Ltd. Sineva focuses on providing AI-based machine vision solutions and advanced materials that cater to semiconductor production and drug development. Its business encompasses four main areas: intelligent manufacturing machinery, advanced materials, artificial intelligence, and aircraft. By addressing critical technical gaps in the domestic pan-semiconductor industrial robot sector, Sineva positions itself as a key player in the evolving landscape of intelligent manufacturing.
Lianbo Precision
Series B in 2022
Jiangsu Lianbo Precision Technology Co., Ltd., established in June 2008, specializes in the development and manufacturing of high-end automotive motors and super-precision rotors. The company occupies a production facility exceeding 30,000 square meters and employs around 200 individuals. With a commitment to quality, Lianbo Precision imports advanced high-speed punch machinery and testing equipment, enabling an annual production capacity of over 60,000 tons and a potential output value of 500 million yuan. The company primarily produces rotors for various applications, including EPS motors, ABS motors, cooling fan motors, starter motors, glass lifter motors, and components for new energy vehicles and motorcycles. Additionally, Lianbo Precision manufactures stators and rotors for household appliances and industrial motors. Its client base includes prominent manufacturers from the United States, Japan, Germany, and France, reflecting the company's reputation for providing specialized support to multinational enterprises and leading automotive parts manufacturers globally.
Origin Quantum
Series B in 2022
Origin Quantum is a full-stack quantum computing company based in China. It provides a quantum computing cloud service platform and engages in the development of quantum hardware, control systems, software, and quantum AI to enable practical use of quantum computers beyond laboratories. Established in 2017, the company focuses on accelerating the engineering, deployment, and industrialisation of quantum computing in China by offering a superconducting quantum computing cloud and related ecosystem.
Canhelp Genomics
Series B in 2022
Canhelp Genomics is a prominent healthcare company specializing in molecular diagnostics and personalized medicine in the oncology sector in China. The company employs advanced technology to address diagnostic uncertainties, providing reliable and actionable evidence that enhances patient care. By enabling accurate disease diagnosis, Canhelp Genomics assists physicians in aligning patients with tailored treatment options, thereby contributing to improved health outcomes in cancer management.
China Resources Vanguard
Funding Round in 2022
China Resources Vanguard, doing business as China Resources Vanguard Shop or Vanguard, operates the supermarket chains of China Resources. It is the third-largest supermarket chain in Hong Kong. As of December 31, 2014, there are 4866 shops operating in Hong Kong and the mainland Chinese provinces/municipalities of Guangdong, Zhejiang, Jiangsu, Shanghai, Tianjin and Beijing.
According to market research firm EuroMonitor's estimates in 2012, China Resources Vanguard supermarket market share in Hong Kong is about 7.8%. Wellcome Hong Kong's market share is about 39.8% and PARKnSHOP Hong Kong's market share is about 33.1%.
On August 18, 2013, China Resources Enterprise's supermarket chain Vanguard and British supermarket Tesco signed a "memorandum of understanding", intending to set up a joint venture interest group in mainland China, Hong Kong and Macau, operating hypermarkets, supermarkets, convenience stores, liquor stores and cash and carry businesses. China Resources Enterprise took an 80% share and Tesco took a 20% share.
NaaS Technology
Series A in 2022
NaaS Technology specializes in electric vehicle charging services for operators and owners. It offers comprehensive solutions covering the entire EV value chain, including online, offline, and non-electric services. As of a certain point, it had connected over 290,000 chargers with an annual capacity exceeding 1,200 gigatonnes. The company aims to enhance charging efficiency and integrate these facilities into China's energy infrastructure, contributing to the nation's carbon neutrality goals.
Tongxin Medical Equipment
Series D in 2022
Tongxin makes magnetically-suspended artificial blood pumps which are designed to replace the human heart. They are undergoing clinical trials in China after being fast-tracked through the approval process by the National Medical Products Administration, state-run Xinhua News Agency
DiShangTie Car Rental (Shenzhen) Co., Ltd. is a company based in Shenzhen, China, specializing in the rental and maintenance of commercial electric vehicles (EVs) for passenger and cargo transportation. Established in 2015, the company focuses on the transportation and logistics sector, providing sustainable energy vehicle rental services tailored for the new energy logistics market. DiShangTie also manufactures electric car charging stations, supporting its commitment to offering green and sustainable vehicle leasing alternatives to major express logistics and urban distribution companies. Through its services, the company aims to facilitate the adoption of environmentally friendly transport solutions in China.
Waytous is a technology company based in Qingdao, China, specializing in autonomous driving solutions for the mining and construction sectors. Established in November 2014, Waytous develops a cloud-based intelligent driving technology that facilitates unmanned operation of mining trucks and collaborative management of excavators. The company emphasizes the creation of training data and a research and development ecosystem tailored to intelligent vehicle applications, enabling clients to enhance the performance and reliability of their autonomous systems.
Value Simplex
Series B in 2021
Value Simplex is a company that specializes in big data, machine learning, and management services tailored for the financial industry. Established in 2017 and headquartered in Shanghai, China, it develops intelligent investment decision-making tools that offer alternative data for projecting company performance and products. Value Simplex also cultivates external data through a platform that utilizes machine learning, allowing clients to improve the accuracy and efficiency of their investment research. By providing long-term data accumulation and insights from time-series data, the company equips its customers with the necessary resources to enhance their investment decision-making processes.
JYBD provides a comprehensive service platform for the entire industry chain of the O2O deep integration of the automotive aftermarket.
CAB is a comprehensive service platform for the entire industry chain of the O2O deep integration of the automotive aftermarket based on the "industry + internet" model and jointly established by industry channel dealers. Acetin aims to use the Internet to promote the transformation of traditional industries, reduce transaction links, reduce costs, improve industrial efficiency, build a router for the automotive industry, and jointly build a new ecosystem for the automotive aftermarket network.
As a platform eco-type Internet enterprise, EPDM has platform service capabilities covering the commercial vehicle + passenger car business group, and On line supply chain + Off line channel operation capabilities, providing service solutions for the entire EPDM industry chain; at the same time as a The service platform for operating 2B & 2C business not only has the ability to integrate offline channels, but also has the full support of many first-class brand supplier groups.
Based on the above characteristics, CABNET promotes the Internetization of traditional enterprises, transforms existing businesses with big data, optimizes the supply chain system, reduces costs, improves industrial efficiency, and integrates logistics, capital flow, information flow, business flow, and people flow in a platform-wide industry. The chain is opened, and the scenes of the various after-market transactions in the automotive after-market are presented in a panoramic manner, forming a large ecosystem in which all roles participate together, and eventually becoming an infrastructure platform for the e-commerce transformation of the automotive after-market.
Beginning in 2017, the headquarters of EPDM moved to Zhongguancun in Beijing, and the leading companies across the country were formed to form EPDM (Beijing) E-commerce to conduct business nationwide. After years of trial, error correction and accumulation of experience, CABNET has matured its business model. Not only does it have a mature e-commerce system and a well-run model market, it can also have a nationwide offline channel network and a professional operation team. , Has the irreproducible resource advantages of the Chinese tire industry and even the automotive aftermarket.
In 2018, the company has successively won tens of millions of CITIC Construction Investment led the Pre-A round, and Manbang Group led the A round of 300 million RMB investment. As of the end of January 2019, it has covered 26 provincial-level administrative regions, 110,000 stores, and 6,200 suppliers. In March, the total monthly platform sales exceeded 500 million yuan, an increase of more than 15% from the previous month, and the annualized transaction volume exceeded 5 billion. yuan.
A-People's mission is to "unify the world's stores, so that business is no longer difficult to do"; adhering to the values ​​of customer success and passion; strive to build A-People's Network into an integrated platform for the industry's supply chain, a platform for gathering industry data, and industry standards Output platform. CAB will focus on the automotive aftermarket, unite resources, establish standards, and jointly build a new ecosystem for the automotive aftermarket.
River Security
Series C in 2021
River Security is a cybersecurity company that specializes in fraud risk protection and innovative dynamic application security solutions. Founded in 2012 and headquartered in Shanghai, with additional offices in Beijing and Shenzhen, the company has developed cutting-edge active defense security technology after extensive research and development. This technology challenges traditional security paradigms that have been in place for over two decades, enabling more effective and timely defenses against a wide range of modern cyber threats. River Security's products include a dynamic security bot-gate that predicts server behavior by transforming the underlying code of web pages, thereby enhancing the protection of corporate website applications and safeguarding business data. The company's approach not only improves security measures but also reduces deployment and operational costs for users.
Innoforce Pharmaceuticals
Series A in 2021
Innoforce Pharmaceuticals Co., Ltd is a biopharmaceutical company based in Hangzhou, China, founded in 2018. The company specializes in the development and commercialization of biomedicines and therapies, including cell and gene therapies, medicines, and antibodies. Innoforce operates biologic process development laboratories and offers end-to-end contract development and manufacturing services to support biotech enterprises in their research and development and manufacturing needs. By providing customized product development and operations management, Innoforce enables its clients to effectively bring their biopharmaceutical products to market.
Hua Kong TsingJiao
Series B in 2021
Hua Kong TsingJiao is an IT company based in Haidian District, Beijing, China, established in 2018. The company specializes in the research, development, and construction of advanced technologies rooted in modern cryptography and game theory. It has developed a cybersecurity platform aimed at ensuring data safety through innovative privacy computing technologies. These technologies utilize multi-party secure computing, allowing multiple non-mutually trusted databases to conduct efficient data fusion while maintaining confidentiality. Additionally, Hua Kong TsingJiao's computing platform supports various general computing types and is compatible with popular function libraries such as NumPy and PyTorch, thereby easing the learning curve for users engaged in ciphertext calculations.
VisionNav Robotics
Series C in 2021
VisionNav Robotics Limited is a Shenzhen-based company founded in 2015 that specializes in designing and manufacturing autonomous industrial vehicles and intralogistics automation solutions. Utilizing advanced technologies such as artificial intelligence, environmental perception, and deep learning, VisionNav has developed a range of products, including vision navigation unmanned forklifts and tractor trucks. The company caters to various sectors, including e-commerce logistics, aviation logistics, and third-party logistics, aiming to enhance efficiency in global logistics operations. With innovations like high-density material storage and automated truck loading, VisionNav has successfully implemented its solutions across more than 50 projects in diverse industries, including automotive, food, and pharmaceuticals.
OrbusNeich Medical
Series B in 2021
OrbusNeich Medical is a global leader in vascular intervention solutions. It offers an extensive range of products that set industry standards.
MediTrust Health
Series C in 2021
MediTrust Health is a leading healthcare platform in China that offers a wide range of health insurance products and comprehensive medical services. The company connects pharmaceutical companies, insurers, hospitals, and patients, creating a cohesive ecosystem that benefits all stakeholders involved. By integrating high-quality medical resources with health insurance, MediTrust Health aims to deliver affordable, personalized healthcare solutions to families. In addition to its insurance offerings, the company focuses on improving the management of medical expenses and enhancing patient access to necessary services through innovative payment solutions. MediTrust Health's commitment to addressing the complexities of medical financing and providing diverse healthcare benefits positions it as a significant player in the healthcare industry.
MicroPort CRM
Series C in 2021
MicroPort CRM is a leading company in the field of Cardiac Rhythm Management, headquartered in Clamart, France. As a subsidiary of MicroPort Scientific Corporation, it specializes in the design, development, and commercialization of advanced medical devices aimed at treating cardiac rhythm disorders and heart failure. The company's product portfolio includes cardiac pacemakers, implantable cardiac defibrillators, cardiac resynchronization systems, and ECG diagnostic solutions. MicroPort CRM's commitment to innovation is evident in its research and development efforts, which focus on improving treatment options for arrhythmias and enhancing patient outcomes. Its manufacturing facilities are located in Clamart, France, Saluggia, Italy, Santo Domingo, Dominican Republic, and Shanghai, China, ensuring a robust production capability to meet global demand.
CalmCar Vision System
Series C in 2021
CalmCar Vehicle Vision is a Chinese intelligent driving vision system provider. They are specialized in developing intelligent vision system for ADAS, autopilot and autonomous driving with functions of Lane Departure Warning (LDW), Front Collision Warning (FCW), Pedestrian Collision Warning(PCW), Blind Spot Detection (BSD) and Traffic Sign Recognition (TSR).
Leyan Technologies
Series D in 2021
Leyan Technologies is an artificial intelligence company founded in April 2016 and headquartered in Shanghai, China. Specializing in software as a service (SAAS), Leyan develops an AI technology platform that offers digital solutions primarily for the robotics industry. The company's innovations are applied in various sectors, including e-commerce customer service, financial consulting, and medical consultation. By focusing on enhancing human-computer interaction, Leyan Technologies aims to improve customer experiences through intelligent customer service robots and tailored AI applications.
Founded in 2017, Xreal is a pioneering developer of ready-to-wear mixed reality glasses. Its flagship product, Nreal Light, offers lightweight comfort and vivid display, enhanced by spatial computing algorithms for an immersive user experience. The company's mission is to make mixed reality accessible to all, empowering developers to create innovative applications across entertainment and productivity.
Ascentawits Pharmaceutical
Series A in 2021
Ascentawits Pharmaceuticals Ltd. is a biotechnology company founded in 2014 and headquartered in Shenzhen, China. The firm specializes in the development of anti-tumor drugs, particularly focusing on small molecule targeted conjugated therapies. Ascentawits employs innovative drug design and screening techniques that leverage specific tumor micro-environments to create effective treatments for cancer patients. Through its research and development efforts, the company aims to improve therapeutic options for individuals battling various forms of cancer.
Miaoshou Doctor
Series E in 2021
Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.
Dobot
Venture Round in 2021
Dobot is a prominent provider of robotic arm solutions based in China, focusing on making technology accessible and enjoyable. The company specializes in the development of smart desktop robotic arms that enhance manufacturing process efficiency. These robotic arms can be controlled through mobile devices, voice commands, and gestures, offering versatile and responsive solutions tailored for various industries. By integrating full-sensing capabilities, Dobot's products enable users to improve product quality and work efficiency. From its inception with the first desktop robotic arm to the development of STEAM robot kits, Dobot continuously innovates to expand the possibilities of robotic technology.
Guangzhou WeRide Technology Co., Ltd. specializes in developing autonomous driving technology for level 4 vehicles, including its own hardware solutions that ensure comprehensive sensor coverage. Founded in 2017 and headquartered in Guangzhou, China, WeRide has established research and development centers across several major cities in China, as well as in Silicon Valley. The company has received strategic investments from leading global automotive groups and holds the distinction of being the first startup to obtain driverless test permits in both China and the United States. In November 2019, WeRide launched its first publicly accessible Robotaxi service in Guangzhou, which covers an area of 144 square kilometers and has since integrated with Amap, a popular ride-hailing app in China. The service has completed over 147,000 trips for more than 60,000 passengers within its first year. WeRide's offerings include a range of autonomous vehicles, such as Robotaxis, Robobuses, and Robovans, and the company continues to focus on enhancing safety and efficiency in transportation.
Core Medical Technology
Series B in 2021
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment.
The company was founded in 2016 and is based in Shenzhen, China.
Singlera Genomics
Series B in 2020
Singlera Genomics Inc. is a biotechnology company that specializes in genetic testing and molecular diagnostic technologies. Founded in 2014 and headquartered in La Jolla, California, with additional operations in Shanghai, China, Singlera develops a methylation detection platform designed for early cancer diagnosis and prevention. The company offers a range of services, including tumor diagnosis, personalized treatment, non-invasive prenatal diagnosis, and pre-implantation genetic screening. Additionally, Singlera is focused on advancing precision medicine, aiming to provide patients with early, accurate, and informative diagnostic solutions to improve healthcare outcomes.
GalaxySpace
Series C in 2020
Founded in 2016, GalaxySpace specializes in developing and manufacturing low Earth orbit (LEO) broadband satellite constellations for global internet connectivity. Their satellite applications include monitoring services for airports, parking lots, oil reserves, and land use assessment.
SequoiaDB
Series D in 2020
SequoiaDB Corporation is a distributed database company based in Shenzhen, China, founded in 2011. It specializes in developing enterprise-class distributed relational databases, notably SequoiaDB, designed for core online transactions, data center operations, and content management. The company also offers SequoiaCM, an enterprise content management solution that addresses the challenges of storing and managing large volumes of unstructured data for medium and large enterprises. SequoiaDB's suite of products supports various applications, including online transaction businesses and data lake solutions, and it primarily serves clients in the financial sector, such as banks, insurance companies, and securities firms. The company has gained recognition in the database industry for its innovative approach and has been featured in Gartner’s reports as a leading provider of advanced database systems.
ThreatBook
Series D in 2020
ThreatBook, established in 2015, is a prominent provider of cyber threat detection and response solutions. The company offers a sophisticated threat intelligence analysis platform that utilizes machine learning to process and analyze cyber threat data, enabling organizations to effectively defend against complex cyber attacks. ThreatBook integrates a full life cycle threat detection system with incident response capabilities, facilitating efficient protection across cloud, network, and endpoint environments. The company has received numerous accolades, including recognition on the Cybersecurity 500 list and being the only Chinese vendor featured in Gartner's Market Guide for Security Threat Intelligence Products and Services for four consecutive years. Additionally, ThreatBook ranked first in the leader quadrant growth index in Frost & Sullivan's China Threat Intelligence Market Report for 2022 and was acknowledged as a Strong Performer in Gartner Peer Insights' Voice of the Customer report for Network Detection and Response in 2023. Serving customers in various industries such as finance, energy, intelligent manufacturing, and the internet, ThreatBook is committed to enhancing security operations and reducing complexity in threat response.
LinkDoc Technology Limited, founded in 2014 and headquartered in Beijing, China, specializes in developing medical data solutions and big data platforms focused on oncology. The company provides clinical structured data services to oncology hospitals, enabling them to address scientific and clinical challenges effectively. LinkDoc is dedicated to offering continuous care for patients with critical diseases and delivers data-driven precision life sciences solutions that facilitate clinical research and enhance real-world adoption for life sciences companies and healthcare providers. Additionally, LinkDoc ensures that its private hospital deployments comply with US HIPAA Act standards, implementing robust security measures to protect patient privacy and data integrity.
Ruipeng Pet Healthcare
Venture Round in 2020
Ruipeng Pet Hospital, located in Shenzhen, specializes in a comprehensive range of pet care services. The hospital provides medical and beauty care for pets, including healthcare, foster care, bathing, SPA treatments, grooming, food, and entertainment. By offering both digital and clinical services, Ruipeng aims to ensure that pet owners can access high-quality care for their animals efficiently. The organization also includes online shopping options to further support pet owners in meeting their pets' needs.
Thousand Oaks Biopharmaceuticals
Series B in 2020
Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and headquartered in Haimen, China, specializes in contract development and manufacturing services for the biotechnology industry. The company focuses on developing technologies to produce protein and vaccine compounds, offering integrated control solutions that optimize processes, increase protein expression, and reduce production scale. Thousand Oaks provides personalized, chemically defined cell culture media, formula production, technical support, and ancillary services to its clients in the biopharmaceutical sector.
Missfresh
Series E in 2020
Beijing Missfresh E-Commerce Co., Ltd. is an e-commerce platform based in Beijing, China, that specializes in the delivery of fresh grocery products. Founded in November 2014, the company operates a mobile application that allows consumers to conveniently purchase a wide range of items, including fruits, vegetables, dairy products, meat, seafood, beverages, and snacks. Missfresh's services are available in 20 cities across China, providing an integrated online-and-offline shopping experience. The platform emphasizes high-quality fresh food and facilitates quick delivery to customers' doorsteps through its dedicated delivery riders.
Yellow Swan
Series A in 2020
Yellow Swan Edible Fresh Eggs is a domestic enterprise based in Chengdu, Sichuan, China, specializing in the production and retail of bacteria-free raw edible eggs. Founded in 2018, the company focuses on providing eggs that are free from Salmonella, ensuring a higher standard of food safety and quality for consumers. By prioritizing hygiene and health, Yellow Swan aims to enhance the overall eating experience while addressing concerns related to foodborne illnesses.
Jushuitan Network Technology
Series C in 2020
Shanghai Jushuitan Network Technology Co., Ltd. specializes in developing software as a service (SaaS) enterprise resource planning (ERP) solutions. Established in 2014 and headquartered in Shanghai, China, the company offers a range of applications that facilitate order management, warehouse management, supply chain management, and distribution management for e-commerce platforms. In addition to its software solutions, Jushuitan Network Technology is involved in the ownership of intellectual property rights, further enhancing its capabilities in the technology sector.
Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP Biopharma. It also is developing two clinical stage drug candidates: MIL60, a biosimilar to Genentech's Avastin, and MIL62, a proposed treatment for chronic lymphocytic leukemia.
Suzhou Ribo Life Science
Series C in 2020
Suzhou Ribo Life Science Co., Ltd. is a biotechnology company specializing in the development of nucleic acid drugs based on RNA interference (RNAi) technology. Established in 2007 and located in Kunshan, China, the company focuses on various aspects of RNAi, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics/pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science develops siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has formed a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its capabilities in the field. Through its innovative approach, Suzhou Ribo Life Science aims to provide more effective pharmaceutical solutions for healthcare providers and patients.
Abbisko Therapeutics
Series C in 2020
Abbisko Therapeutics is a clinical-stage biopharmaceutical company focused on discovery and development of differentiated small-molecule oncology therapies. Based in Shanghai, China, and founded in 2016, the company emphasizes immuno-oncology and aims to advance cancer treatments through in-house research and development, with a focus on therapies for hepatocellular carcinoma and solid tumors.
Lansus Technologies
Series B in 2019
Lansus Technologies Inc. is a fabless semiconductor company founded in 2015 and headquartered in Shenzhen, China, with a research center located in Shanghai. The company specializes in developing advanced chip solutions, focusing on radio frequency power amplifiers, switches, and radio-frequency front-end modules. Lansus Technologies provides industrial clients with power amplification solutions through wireless RF devices and systems, catering to sectors such as mobile communications, IoT home furnishings, and industrial electronics. With a commitment to promoting technological progress, the company emphasizes advancements in the radio frequency field while prioritizing sustainable development. Its product offerings include solutions for 5G and 4G wireless communications.
DataExa is a comprehensive artificial intelligence empowerment platform focused on delivering tailored AI solutions across multiple industries. The company has developed a range of products, including its flagship DataExa-Sati Cognitive Intelligence Platform, which leverages general knowledge graph technology. Other notable offerings include the DataExa-Maya intelligent question-answering platform, the DataExa-Kamala natural language processing platform, and the DataExa-Rama search platform. These tools have been successfully implemented in sectors such as defense, banking, securities, public security, civil aviation, and healthcare. By emphasizing value discovery, utilization, and innovation, DataExa creates self-learning industry knowledge maps that enhance big data solutions, enabling organizations to effectively incorporate data and knowledge mapping into their operations.
GeneCast Biotechnology
Series D in 2019
GeneCast Biotechnology Co., Ltd. is a Beijing-based company founded in 2014, specializing in gene research and cancer diagnostics. The company offers a technology platform for cell-free DNA next-generation sequencing (NGS) tests, which include companion diagnostics, genetic profiling, prognosis, and monitoring for various solid tumors. GeneCast provides solutions for cancer treatment and genetic testing, focusing on tumors such as lung, colorectal, liver, and breast cancers. Its non-invasive diagnostic methods leverage high-throughput sequencing and bioinformatics to enable personalized medicine, aiming to improve patient outcomes and quality of life. The company collaborates with hospitals and research institutions to advance its capabilities in detecting tumors and cancer-related genes in blood.
Transwarp
Series D in 2019
Transwarp is a technology company based in Shanghai that specializes in big data software solutions for enterprises. It offers a cloud-based platform that serves as an integrated system for data processing and cloud operations. This platform facilitates the management and analysis of data, allowing businesses to effectively store and govern their data throughout its entire life cycle. Additionally, Transwarp provides services related to data integration, modeling, analysis, mining, and circulation, enabling organizations to harness the full potential of their data infrastructure.
X-Giants is a human resources solution provider headquartered in Shanghai, China, established in 2005. The company specializes in various recruitment services, including talent search, recruitment process outsourcing, flexible employment options, and personnel outsourcing. In addition to these services, X-Giants offers consulting and training solutions, as well as salary and benefits management. The firm also engages in innovative initiatives, such as forming the "blockchain+human resources ecological alliance," to enhance its service offerings. By focusing on mid-to-high-end headhunting and comprehensive HR solutions, X-Giants aims to address the diverse needs of its clients in the evolving labor market.
JD Logistics
Series A in 2019
JD Logistics is a technology-driven supply chain solution and logistics service provider in China. It offers a full spectrum of services, including warehousing, distribution, and specialized items delivery, serving various industries such as fast-moving consumer goods, apparel, home appliances, and automotive.
Unisound is a Chinese mobile internet startup focusing on intelligent voice and speech processing technologies. Founded in June 2012, the company owns speech recognition technologies with independently developed intellectual property. Leveraging cloud computing and mobile internet, it launched middleware and cloud platforms for speech recognition services, providing internet enterprises and users with professional speech recognition services. Its core technology team comprises members from major companies, universities, and research institutes, with over 80% holding doctoral degrees and more than 10 years of R&D experience in voice recognition.
Abbisko Therapeutics
Series B in 2019
Abbisko Therapeutics is a clinical-stage biopharmaceutical company focused on discovery and development of differentiated small-molecule oncology therapies. Based in Shanghai, China, and founded in 2016, the company emphasizes immuno-oncology and aims to advance cancer treatments through in-house research and development, with a focus on therapies for hepatocellular carcinoma and solid tumors.
Jusda International Supply Chain Management Co., Ltd., founded in 2000 and based in Shenzhen, China, specializes in providing comprehensive supply chain management services. The company serves as a platform for freight and logistics solutions, including e-commerce supply chain services on an international scale. As a key service provider for Foxconn Technology Group, Jusda is focused on enhancing the efficiency and professionalism of supply chain management through advanced technology and research and development. Its innovative business model integrates multiple flows—trading, goods, information, capital, technology, and processes—aiming to streamline operations and drive growth within the supply chain sector.
Tenry Pharmaceutical
Series B in 2019
Shanghai Tenry Pharmaceutical Company Limited (Tenry) is a modern pharmaceutical enterprise based in Shanghai, specializing in the development and production of biopharmaceuticals, pharmaceutical raw materials, and chemical drugs. The company operates two advanced manufacturing plants and has achieved approval for 73 national drugs, including two biological agents. Tenry's primary focus includes research and development, sales and marketing, and regulatory compliance, allowing it to provide innovative treatments for patients. Its leading products address critical needs in bleeding management and wound management, positioning Tenry as a significant player in the pharmaceutical industry.
Xingkeduo
Series B in 2018
Xingkeduo is a modern hair salon brand based in Beijing, China, founded in 2015. The company operates nearly 100 locations, employing over 320 hairdressers. It leverages technology, including Internet tools and big data systems, to enhance the haircut experience, focusing on efficiency and customer convenience. With a franchise model, Xingkeduo targets quick services, such as 15-minute haircuts, allowing clients to easily book and pay for appointments through WeChat. The company's commitment to data management and standardized operations aims to improve service delivery while fostering a better working environment for its craftsmen.
Tuhu operates an integrated online and offline platform for automotive services in China, delivering same-day or next-day delivery of after-sales products and installation services to customers across mainland China in over 260 cities. It serves online channels through its website, mobile app, call center, and third-party e-commerce platforms, and offline via self-operated workshops, franchised workshops, and third-party partner stores. The platform aggregates diverse car service needs for passenger vehicles, including tires, chassis parts replacement, maintenance, repair, and detailing, through its TUHU Automotive Service app and related interfaces, providing a centralized, on-demand service experience.
Makeblock
Series C in 2018
Makeblock, established in 2013 by Jasen Wang and headquartered in Shenzhen, China, specializes in a do-it-yourself robotics construction and programming learning platform. This platform provides mechanical parts, electronic modules, and graphical programming software, empowering STEM learners, educators, and hobbyists to build and customize robots with versatile functionalities like hovercrafts or cars.
Shanghai Henlius Biotech
Venture Round in 2018
Shanghai Henlius Biotech, Inc. is a biopharmaceutical company based in Shanghai, China, specializing in the research, development, production, and commercialization of biologics, particularly monoclonal antibody (mAb) biosimilars and novel therapies. Founded in 2010, the company focuses on oncology and autoimmune diseases, offering products such as HLX01, a biosimilar for treating non-Hodgkin lymphoma. Henlius is actively advancing its pipeline, with multiple products under review for regulatory approval, alongside conducting numerous clinical studies for various therapies. The company collaborates with partners, including agreements to develop treatments for COVID-19 and eye diseases. Shanghai Henlius Biotech is a joint venture between Shanghai Fosun Pharmaceutical and Henlius Biopharmaceuticals, established in 2009, and operates out of the Shanghai Caohejing High-Technology Park.
Xpeng Motors
Series B in 2018
Xpeng Motors is a Chinese electric vehicle and technology company that specializes in the design and manufacture of smart cars. The company emphasizes local market needs and prioritizes consumer experience, integrating advanced autonomous driving features and internet-connected technologies into its vehicles. This approach aims to enhance the overall functionality and appeal of their cars, making them more than just traditional vehicles. Additionally, Xpeng Motors has a subsidiary, Xpeng Robotics, which focuses on developing smart robots as part of its broader mobility ecosystem.
Zing Home
Corporate Round in 2017
Zing Home is a Shenzhen-based household products and furniture retail brand. It currently operates in 46 cities across China with over 160 offline stores.
Gaosi Education Group
Series C in 2017
Gaosi Education Group is a Chinese educational institution specializing in extracurricular tutoring for middle and primary school students. Founded in December 2009, it is headquartered in Beijing's Haidian District. The group focuses on gifted education, offering tailored courses for students from primary through junior high school. It features personalized one-on-one teaching centers and emphasizes mathematics competitions as a key component of its curriculum. With nearly 10,000 students enrolled, Gaosi Education Group employs around 100 full-time teachers and staff dedicated to teaching and research.
United Imaging Healthcare
Series A in 2017
United Imaging Healthcare develops and manufactures a wide range of medical equipment and solutions, focusing on diagnostic imaging, radiotherapy, and healthcare information technology. The company's product offerings include advanced imaging devices such as computed tomography, molecular imaging, magnetic resonance systems, and digital radiography solutions. Notable products include the uCT 510, uMI 510 PET-CT scanner, and uMR 560 imaging device. Additionally, United Imaging provides the uCloud UIH Intelligent Medical Cloud platform for resource sharing and data analysis. The company also offers comprehensive customer support, technical assistance, and training services. Established in 2011 and headquartered in Shanghai, China, United Imaging Healthcare has expanded its operations to various locations, including the United States, with facilities in cities like Concord, Cleveland, and Houston. The company has strategic partnerships to enhance its offerings and reach in the healthcare sector.
Distinct HealthCare
Series C in 2017
Distinct HealthCare is a private healthcare provider operating approximately 20 clinics across six cities in China, including Shenzhen, Hong Kong, Guangzhou, and Beijing. Founded in 2012, the company focuses on delivering patient-oriented and quality-assured medical services. Its clinics offer a range of medical specialties, including pediatrics, internal medicine, gynecology, and family medicine, addressing various health issues such as common colds, diabetes, and chronic kidney disease. Distinct HealthCare also provides emergency support, facilitates referrals to specialists, and conducts essential examinations and laboratory tests. Additionally, the company offers nursing services and well-baby plans, ensuring comprehensive care for patients. By employing doctors from prestigious medical institutions, Distinct HealthCare emphasizes appropriate treatment suggestions while minimizing unnecessary antibiotic prescriptions and examinations. The company has established a strategic partnership with Tencent Holdings Limited to enhance its service delivery.
SenseTime
Series B in 2017
Founded in 2014, SenseTime specializes in artificial intelligence technologies, focusing on computer vision and deep learning. It offers a range of AI solutions including face and body analysis, image recognition, video comprehension, SLAM and 3D Vision, robot sensing, autonomous driving, medical image analysis, and AI supercomputing platforms. Serving sectors such as smart city, mobile, entertainment, automobile, health, business, education, and advertising worldwide, SenseTime operates offices in major cities across Asia.
XG Entertainment
Series B in 2017
XG Entertainment Co., Ltd., founded in 2015 by Yang Wenhong, is a Shanghai-based company specializing in the production of television and online dramas. The firm focuses on creating high-quality entertainment content across multiple sectors, including film and television, variety shows, live performances, and short video professionally generated content. Notable products include the online animation drama "Quanzhifashi," based on an online novel, and a Food TV show. In addition to production services, XG Entertainment also provides online advertising and engages in offline entertainment activities, further diversifying its offerings in the entertainment industry.
QingCloud
Series D in 2017
QingCloud is a technology enterprise based in China that offers a cloud computing platform focused on Infrastructure as a Service (IaaS). The company provides a range of flexible cloud services, including private networking, real-time computing, open APIs, comprehensive monitoring, and robust security policies. Founded by former employees of Tencent, Baidu, and IBM, QingCloud aims to create an optimized IaaS platform that meets significant technological needs. The company's CEO has articulated a vision for QingCloud to emerge as a globally recognized cloud provider. With plans to expand its operations into the Asia Pacific region, QingCloud is committed to delivering innovative, reliable, and flexible solutions that support digital transformation for enterprises.
NetEase Cloud Music
Series A in 2017
NetEase Cloud Music, established in 2013 and based in Hangzhou, China, specializes in online music streaming services through its mobile application. The platform enables users to access a wide variety of music and offers additional features, such as music discovery and social networking capabilities. As a subsidiary of NetEase, Inc., NetEase Cloud Music has grown to become a significant player in the Chinese music streaming market, catering to the evolving preferences of its audience while developing applications for smartphones to enhance user experience.
UCloud Information Technology
Series D in 2017
UCloud Information Technology specializes in cloud computing technology, offering a range of solutions that include Infrastructure as a Service (IaaS), Platform as a Service (PaaS), and big data and artificial intelligence services. Founded in 2011 and headquartered in Shanghai, China, the company develops its own cloud computing products, such as UCloud Physical Host, UCloud Host, and UCloud Load Balancer, which facilitate resource management and application data distribution. UCloud also provides services like UCloud Disk for storage, UCloud DataBase for data management, and cloud security solutions. The company serves various sectors, including e-commerce, online education, and digital marketing, delivering both public and private cloud solutions tailored to meet diverse customer needs. UCloud’s commitment to independent research and development underlines its position as a secure and neutral cloud service provider.
Lachesis is a high-tech company based in Shenzhen, China, specializing in clinical applications that integrate information and communications technology with internet technology. The company develops intelligent products and services aimed at enhancing the efficiency of healthcare delivery for doctors, nurses, patients, and hospitals. Its offerings include a bedside nursing solution, an interactive smart ward solution, and an IoT platform, all designed to improve management efficiency and accuracy in medical assessments. By providing mobile medical intelligent hardware and application software, Lachesis aims to advance mobile nursing and intelligent medical practices within healthcare institutions.
Chunyu Yisheng
Series D in 2016
Chunyu Yisheng, established in 2011 and headquartered in Beijing, is a mobile application designed to enhance communication between physicians and patients. The app allows doctors to access their patients' medical records and facilitates direct interaction, enabling patients to schedule appointments and communicate with their healthcare providers. Additionally, Chunyu Yisheng offers reservation line treatment services, further supporting users in managing their health. The company focuses on leveraging Internet technology to improve health outcomes and streamline the healthcare experience.
Circle is a Boston-based fintech company founded in 2013 by Jeremy Allaire and Sean Neville. It specializes in utilizing stablecoins for payments, e-commerce, and investment products. Circle's services include Circle Pay for easy money transfers, Circle Invest for crypto asset trading, and Circle Trade for over-the-counter transactions. The company is backed by prominent investors such as Jim Breyer, Goldman Sachs, IDG Capital, General Catalyst, and Accel Partners.
UCAR Technology
Series C in 2016
UCAR Technology, established in 2015 and headquartered in Tianjin, China, is a prominent provider of chauffeured car services. The company operates an on-demand car-hailing platform that connects customers with local licensed drivers through their smartphones. UCAR combines mobile internet technology, big data, and a fleet of quality rental vehicles to ensure safe and standardized transportation. The company's services include both chauffeured car options and vehicle rentals, with a focus on driver qualifications and vehicle conditions. UCAR employs advanced technologies to monitor driver behavior, ensuring privacy protection and efficient response to accidents, thereby enhancing the overall customer experience.
Bairong is an independent technology platform based in China that specializes in providing financial information services to large companies. Utilizing artificial intelligence, cloud computing, and blockchain technology, Bairong aims to innovate and digitally transform the financial services industry. The company focuses on exploring various scenarios and applications of these advanced technologies, enabling financial institutions to enhance their operations and promote financial inclusion. Through its AI-powered solutions, Bairong supports financial institutions in navigating the complexities of the modern financial landscape.
Tellyes Scientific
Post in 2015
Tellyes Scientific Inc. is a manufacturer and marketer of healthcare equipment specifically designed for medical education and training. Established in 2001 and headquartered in Tianjin, China, the company develops a wide range of products including patient simulators, surgical simulators, ultrasound and imaging simulators, task trainers, and dental simulators, as well as offerings for traditional Chinese medicine. Tellyes Scientific also provides comprehensive solutions for planning and managing training centers, including tele-simulation services. With a focus on innovation and research, the company produces over a thousand different types of medical virtual teaching products, serving medical colleges, research organizations, and hospitals across Asia, Africa, the Middle East, Europe, North America, and Latin America.
Daoyoudao is a technology company based in Beijing, China, specializing in digital marketing services. It focuses on user growth for clients across various sectors, including internet, education, and automotive industries. Daoyoudao acquires new users through digital effect marketing strategies such as information flow advertising and short video advertising. Additionally, the company activates existing users by employing programmatic content awakening techniques to enhance customer engagement.
Wacai.com
Series B in 2015
Wacai is a Chinese mobile app developer specializing in personal finance management through its widely-used mobile application. Since its launch in 2009, the app has provided users with bookkeeping services and expanded its functionality to include mutual fund trading in 2013. In 2014, Wacai introduced a credit card manager feature, which has become increasingly popular among users in China. The app aims to help individuals manage their finances effectively by offering tools for personal bookkeeping, credit management, and an online community for financial assistance. With a user base exceeding 40 million, Wacai continues to enhance its platform to meet the evolving needs of its clientele.
ZhongAn Online P & C Insurance Co., Ltd. is an insuretech company based in Shanghai, China, founded in 2013 by prominent enterprises including Ant Financial, Tencent, and Ping An Insurance. As the first internet-based insurance provider in China, ZhongAn exclusively offers its products and services online, eliminating the need for physical branches. The company specializes in property and casualty insurance, providing coverage for accidents, health, liability, cargo, household property, and motor-related incidents. In addition to insurance, ZhongAn also delivers a range of technology services, including IT consulting, asset management, and telemedicine solutions. The company's technological capabilities extend to developing digital operating systems and industry models, which are offered to financial institutions both domestically and internationally. With a focus on e-commerce and mobile payment solutions, ZhongAn supports internet businesses and individual users through financing guarantees and innovative online services.
Lufax is a technology-driven personal financial services platform in China, operating as an associate company of Ping An Insurance. It specializes in wealth management solutions for China's middle class and affluent population, along with retail credit facilitation services.
Chunyu Yisheng
Series C in 2014
Chunyu Yisheng, established in 2011 and headquartered in Beijing, is a mobile application designed to enhance communication between physicians and patients. The app allows doctors to access their patients' medical records and facilitates direct interaction, enabling patients to schedule appointments and communicate with their healthcare providers. Additionally, Chunyu Yisheng offers reservation line treatment services, further supporting users in managing their health. The company focuses on leveraging Internet technology to improve health outcomes and streamline the healthcare experience.
New China Life Insurance
Venture Round in 2011
New China Life Insurance is a major Chinese life insurer founded in 1996 and headquartered in Beijing. It provides life insurance products to individuals and institutions and operates through Individual Insurance, Group Insurance, and Other Business segments. The company also offers asset management, training, electronic commerce, medical services, and real estate investments, and engages in project investments. It maintains an extensive distribution network across provinces and cities through diverse channels. It emphasizes risk control and has a comprehensive risk management framework. The business is partly owned by Huijin Investment, the government's investment arm, reflecting government involvement. It ranks among the largest life insurers in China by assets.